Predictive factors for survival in patients with inoperable Klatskin tumors

Hepato-Gastroenterology

Volumn 53, Issue 67, 2006, Pages 21-27

  Arvanitakis, Marianna ^a   Van Laethem, Jean Luc ^a   Pouzere, Sylvain ^a   Le Moine, Olivier ^a   Deviere, Jacques ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

ERCP; Hilar cholangiocarcinoma; Klatskin tumor

Indexed keywords

BISMUTH; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERBILIRUBINEMIA; INOPERABLE CANCER; JAUNDICE; KLATSKIN TUMOR; LIVER METASTASIS; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; STENT;

AGED; BILE DUCT NEOPLASMS; COHORT STUDIES; DRAINAGE; FEMALE; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33344457591     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Khan SA, Davidson BR, Goldin R, et al: Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51(Suppl VI):vi1-vi9.
2. Jarnagin WR, Fong Y, DeMatteo RP, et al: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-519.
3. Cameron JL, Pitt HA, Zinner MJ, et al: Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990; 159:91-98.
4. Tashiro S, Tsuji T, Kanemitsu K, et al: Prolongation of survival for carcinoma of the hepatic duct confluence. Surgery 1991; 113:270-278.
5. Kawasaki S, Makuuchi M, Miyagawa S, et al: Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg 1994; 178:480-486.
6. Nimura Y, Hayakawa N, Kamiya J, et al: Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 1991; 78:727-731.
7. Hejna M, Pruckmayer M, Raderer M, et al: The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998; 34:977-986.
8. Smith AC, Dowsett JF, Russel RC, et al: Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344:1655-1660.
9. Abraham NS, Barkun JS, Barkun AN, et al: Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002; 56:835-841.
10. Knyrim K, Wagner HJ, Pausch J, et al: A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993; 25:207-121.
11. Wagner HJ, Knyrim K, Vakil N, et al: Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 1993; 25:213-218.
12. Ducreux M, Liguory C, Lefebvre JF, et al: Management of malignant hilar biliary obstruction by endoscopy: results and prognostic factors. Dig Dis Sci 1992; 37:778-783.
13. Bismuth H, Castaing D, Traynor O, et al: Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12:39-47.
14. Byl B, Deviere J, Struelens MJ, et al: Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995; 20:1236-1240.
15. Cremer M, Deviere J, Delhaye M, et al: Stenting in severe chronic pancreatitis. Results of a medium-term follow-up in seventy-six patients. Endoscopy 1991; 23:171-176.
16. Deviere J, Baize M, De Toeuf J, et al: Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988; 34:95-101.
17. Dowsett JF, Vaira D, Hatfield ARW, et al: Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology 1989; 96:1180-1186.
18. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
19. Jarnagin WR, Burke E, Powers C, et al: Intra-hepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg 1998; 175:453-460.
20. Blumgart LH, Benjamin IS, Hadjis NS, et al: Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet 1984; 1:66-70.
21. Soehendra N, Reynders-Frederix V: Palliative bile duct drainage-a new endoscopic method of introducing a transpapillary drain. Endoscopy 1980; 12:8-11.
22. Rege RV: Adverse effects of biliary obstruction: implications for treatment in obstructive jaundice. Am J Roentgenol 1995; 164:287-293.
23. Kramer HJ: Impaired renal function in obstructive jaundice: roles of thromboxane and endothelin systems. Nephron 1997; 77:1-12.
24. Nehez L, Andersson R: Compromise of immune function in obstructive jaundice. Eur J Surg 2002; 168:313-328.
25. Cotton PB, Schmitt C: Quality of life in palliative management of malignant obstructive jaundice. Scand J Gastroenterol 1993; 199:44-46.
26. Glasova H, Beders U: Extra-hepatic manifestations of cholestasis. J Gastroenterol Hepatol 2002; 17:938-948.
27. Cheng JLS, Bruno MJ, Bergman JJ, et al: Endoscopic palliation of patients with biliary obstruction caused by non-resectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002; 56:33-39.
28. Chang WH, Kortan P, Haber GB: Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47:354-362.
29. De Palma GD, Galloro G, Sicillano S, et al: Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001; 53:547-553.
30. Motte S, Deviere J, Dumonceau JM, et al: Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991; 101:1374-1381.
31. Sung JY, Costerton JW, Shaffer EA: Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992; 37:689-696.
32. Polydorou AA, Chisholm EM, Romanos AA, et al: A comparison of right versus left hepatic endoprostheses insertion in malignant hilar biliary obstruction. Endoscopy 1989; 21:266-271.
33. Freeman ML, Overby C: Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 2003; 58:41-49.
34. Hintze RE, Abou-Rebyeh H, Adler A, et al: Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001; 53:40-46.
35. Todoroki T: Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 2000; 47:644-649.
36. Price P: Cholangiocarcinoma and the role of radiation and chemotherapy. Hepatogastroenterology 2001; 48:51-52.
37. Ortner ME, Caca K, Berr F, et al: Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized, prospective study. Gastroenterology 2003; 125:1355-1363.